MASH cirrhosis has traditionally been considered irreversible. However, new data from investigators at Cleveland Clinic, presented at Digestive Disease Week 2026, demonstrate that cirrhosis regression can occur following metabolic and bariatric surgery (MBS). In a retrospective cohort of patients with biopsy-proven compensated MASH cirrhosis undergoing…
The U.S. healthcare system is approaching a tipping point, driven by three converging threats: rising care costs, a growing chronic…
In a bid to close persistent colorectal cancer (CRC) screening gaps, Guardant Health has launched a community grant program offering…
The 2025 Identity Theft Resource Center report confirms what many physician-owners are feeling: cyberattacks are no longer random — they’re…
UMass’ Division of Gastroenterology has completed its first Full-Thickness Resection Device (FTRD) procedure, marking an expansion in advanced endoscopic capabilities.…
DDW 2025
A new DDW 2025 study reveals a surprising truth: most post-polypectomy colorectal…
With 19 million more patients now eligible for colorectal cancer screening, the…
Headlines in GI
The American Gastroenterological Association (AGA) has awarded $2.9 million to 84 researchers,…
Interviews
Is Private Equity a Friend or Foe to Physicians? The Devil Is in the Details (The Commonwealth Fund)
A detailed Commonwealth Fund analysis shows that physician experiences with private equity…
Thought Leadership
A growing message in gastroenterology is that nutrition should no longer be treated as an “adjunct” to care, but as a core clinical intervention.…
At the Cleveland Clinic, the newly formed Endorobotics Collaborative signals a shift…
What to Do When Procedures Are No Longer Enough An upcoming book…
Gastroenterology is rapidly becoming a focal point for innovation, with AI, robotics,…
ARTIFICIAL INTELLIGENCE (AI)
A growing paradox is emerging in medical AI: some of the strongest evidence exists for imaging-based AI tools—across colonoscopy, mammography,…
Tech & Innovation
Neptune Medical reported positive first-in-human results for its Triton Robotic Endoscopy system, with a 50-patient study showing no adverse events and 100% cecal intubation during colonoscopy…
Editor's Picks
MASH cirrhosis has traditionally been considered irreversible. However, new data from investigators…
Business
Olympus has partnered with EndoRobotics to globally distribute robot-assisted technologies for advanced…
Exponential Tech
Neptune Medical reported positive first-in-human results for its Triton Robotic Endoscopy system,…
Leadership
Gastroenterology hospitalists (GIH) have become an integral to academic inpatient gastroenterology services,…
Patient Trends
A new population-based study published in Clinical Gastroenterology and Hepatology evaluated the…
